A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Abroad (travel likely)RecruitingPHASE4

Conditions

Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • HCG City Cancer Centre, Vijayawada, Andhra Pradesh, India

    Contact: Study coordinator (Site Contact) · drpolisetty.a@hcgel.com · 9611165090
    Contact: Principal Investigator (Amarnath Polishetty)
  • Gauhati Medical college and Hospital, Guwahati, Assam, India

  • Unique Hospital Multispeciality and Research Institute, Surat, Gujarat, India

    Contact: Study coordinator (Site Contact) · tanveermaksud@gmail.com · 9909918887
    Contact: Principal Investigator (Tanveer Maksud)
  • HCG Cancer Centre, Bangalore, Karnataka, India

    Contact: Study coordinator (Site Contact) · drnatarajks@gmail.com · 9482141773
    Contact: Principal Investigator (Natraj KS)
  • JIPMER, Puducherry, Kerala, India

  • HCG Manavata Cancer Centre, Nashik, Maharashtra, India

  • ACTREC, Navi Mumbai, Maharashtra, India

  • DMH, Pune, Maharashtra, India

  • Rajiv Gandhi Cancer Hospital, Delhi, New Delhi, India

  • NRS Medical college & Hospital, Kolkata, Kolkata, West Bengal, India

    Contact: Study coordinator (Site Contact) · tkdolai@hotmail.com · 9874890275
    Contact: Principal Investigator (Tuphan kanti Dolai)
  • AIIMS, New Delhi, India

    Contact: Study coordinator (Site Contact) · ajaygogia@gmail.com · 9013000642
    Contact: Principal Investigator (Ajay Gogia)